213 related articles for article (PubMed ID: 12611274)
1. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
Radau G; Stürzebecher J
Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
[TBL] [Abstract][Full Text] [Related]
2. New cyanopeptide-derived low molecular weight inhibitors of trypsin-like serine proteases.
Radau G; Schermuly S; Fritsche A
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):300-9. PubMed ID: 12953218
[TBL] [Abstract][Full Text] [Related]
3. New cyanopeptide-derived low molecular weight thrombin inhibitors.
Radau G; Gebel J; Rauh D
Arch Pharm (Weinheim); 2003 Aug; 336(8):372-80. PubMed ID: 14502757
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors.
Obreza A; Stegnar M; Trampus-Bakija A; Prezelj A; Urleb U
Pharmazie; 2004 Oct; 59(10):739-43. PubMed ID: 15544050
[TBL] [Abstract][Full Text] [Related]
5. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.
Smolnikar I; Perdih A; Stegnar M; Prezelj A; Solmajer T; Urleb U; Obreza A
Pharmazie; 2007 Apr; 62(4):243-54. PubMed ID: 17484277
[TBL] [Abstract][Full Text] [Related]
7. Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position.
Obreza A; Stegnar M; Urleb U
Pharmazie; 2004 Sep; 59(9):659-67. PubMed ID: 15497744
[TBL] [Abstract][Full Text] [Related]
8. Design and X-ray crystal structures of human thrombin with synthetic cyanopeptide-analogues.
Radau G; Fokkens J
Pharmazie; 2007 Feb; 62(2):83-8. PubMed ID: 17341023
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
Wienand A; Ehrhardt C; Metternich R; Tapparelli C
Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
[TBL] [Abstract][Full Text] [Related]
10. Azetidin-2-one derivatives as inhibitors of thrombin.
Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
[TBL] [Abstract][Full Text] [Related]
11. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
12. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
Wang G; Goyal N; Hopkinson B
Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and mechanism of action of novel thiocarbamate inhibitors of human leukocyte elastase.
Li-Pan ZS; Joshi HV; Digenis GA
J Enzyme Inhib; 2000; 15(1):63-77. PubMed ID: 10850955
[TBL] [Abstract][Full Text] [Related]
14. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
15. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
[No Abstract] [Full Text] [Related]
16. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
Karle M; Knecht W; Xue Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.
Ogbu CO; Qabar MN; Boatman PD; Urban J; Meara JP; Ferguson MD; Tulinsky J; Lum C; Babu S; Blaskovich MA; Nakanishi H; Ruan F; Cao B; Minarik R; Little T; Nelson S; Nguyen M; Gall A; Kahn M
Bioorg Med Chem Lett; 1998 Sep; 8(17):2321-6. PubMed ID: 9873535
[TBL] [Abstract][Full Text] [Related]
18. Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis.
Lu T; Markotan T; Coppo F; Tomczuk B; Crysler C; Eisennagel S; Spurlino J; Gremminger L; Soll RM; Giardino EC; Bone R
Bioorg Med Chem Lett; 2004 Jul; 14(14):3727-31. PubMed ID: 15203151
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of N-alpha-(arylsulfonyl)-4-amidino-phenylalanyl-prolines and N-alpha-(arylsulfonylglycyl)-4-amidino-phenylalanyl-prolines and testing of them as inhibitors of serine proteinases. 33. Synthetic inhibitors of serine proteinases].
Voigt B; Stürzebecher J; Wagner G; Markwardt F
Pharmazie; 1988 Jun; 43(6):412-4. PubMed ID: 2974999
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
Xue F; Seto CT
Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
